JP2018521119A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521119A5
JP2018521119A5 JP2018515175A JP2018515175A JP2018521119A5 JP 2018521119 A5 JP2018521119 A5 JP 2018521119A5 JP 2018515175 A JP2018515175 A JP 2018515175A JP 2018515175 A JP2018515175 A JP 2018515175A JP 2018521119 A5 JP2018521119 A5 JP 2018521119A5
Authority
JP
Japan
Prior art keywords
methyl
isopropylthio
pyrazole
thiazol
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018515175A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521119A (ja
JP6707630B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035288 external-priority patent/WO2016196644A1/en
Publication of JP2018521119A publication Critical patent/JP2018521119A/ja
Publication of JP2018521119A5 publication Critical patent/JP2018521119A5/ja
Application granted granted Critical
Publication of JP6707630B2 publication Critical patent/JP6707630B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018515175A 2015-06-01 2016-06-01 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法 Expired - Fee Related JP6707630B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562169376P 2015-06-01 2015-06-01
US62/169,376 2015-06-01
PCT/US2016/035288 WO2016196644A1 (en) 2015-06-01 2016-06-01 Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

Publications (3)

Publication Number Publication Date
JP2018521119A JP2018521119A (ja) 2018-08-02
JP2018521119A5 true JP2018521119A5 (enExample) 2019-10-03
JP6707630B2 JP6707630B2 (ja) 2020-06-10

Family

ID=56118071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018515175A Expired - Fee Related JP6707630B2 (ja) 2015-06-01 2016-06-01 置換ピラゾールおよびピロール化合物、および翻訳開始の阻害およびこれらに関連する疾患および障害の治療のためにこれらを用いる方法

Country Status (9)

Country Link
US (2) US10537558B2 (enExample)
EP (1) EP3303332A1 (enExample)
JP (1) JP6707630B2 (enExample)
CN (1) CN108349962A (enExample)
BR (1) BR112017025851A2 (enExample)
CA (1) CA3025492A1 (enExample)
IL (1) IL255898A (enExample)
MX (1) MX2017015456A (enExample)
WO (1) WO2016196644A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017015456A (es) 2015-06-01 2018-11-29 Bantam Pharmaceutical Llc Compuestos de pirazol y pirrol sustituidos y metodos para su uso por inhibición de iniciación de traducción y tratamiento de enfermedades y trastornos relacionados con ellos.
MX2019006296A (es) 2016-11-30 2019-11-12 Bantam Pharmaceutical Llc Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas.
WO2018102453A1 (en) * 2016-11-30 2018-06-07 Bantam Pharmaceutical, Llc Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
CN111918865B (zh) 2018-03-30 2023-10-27 住友化学株式会社 杂环化合物和含有该杂环化合物的有害节肢动物防除组合物
JP2021527059A (ja) * 2018-06-07 2021-10-11 バンタム、ファーマシューティカル、リミテッド、ライアビリティー、カンパニーBantam Pharmaceutical, Llc 置換ピロール及びピラゾール化合物による癌の治療方法、並びに、置換ピロール及びピラゾール化合物による治療に影響を受けやすい癌の診断
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用
US12358905B2 (en) * 2019-05-31 2025-07-15 Bantam Pharamceutical, LLC Methods for making thiazolypyrazole carboxylic acids and intermediates therefor
US12435076B2 (en) 2019-11-01 2025-10-07 Unimatec Co., Ltd. Fluorine-containing pyrimidine compound and method for producing same
MX2022010944A (es) 2020-03-03 2022-11-09 Pic Therapeutics Inc Inhibidores del factor de iniciacion de traduccion eucariotica 4e (eif4e) y sus usos.
TW202315621A (zh) 2021-08-25 2023-04-16 美商皮克醫療公司 Eif4e抑制劑及其用途
JP2024532276A (ja) 2021-08-25 2024-09-05 ピク セラピューティクス, インコーポレイテッド eIF4E阻害剤及びその使用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342851A (en) * 1992-10-07 1994-08-30 Mcneil-Ppc, Inc. Substituted thiazole derivatives useful as platelet aggregation inhibitors
IT1301968B1 (it) 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
ATE252576T1 (de) * 1999-12-03 2003-11-15 Pfizer Prod Inc Heteroarylphenylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel
US6900219B2 (en) 2002-04-04 2005-05-31 Cv Therapeutics, Inc. ABCA-1 elevating compounds
CA2520870A1 (en) 2003-04-03 2004-10-21 Merck & Co., Inc. Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
US20070060584A1 (en) * 2003-04-18 2007-03-15 Chakravarty Prasun K Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
WO2007138110A2 (en) 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2008121861A2 (en) 2007-03-28 2008-10-09 Xenon Pharmaceuticals Inc. Pyrazole and pyrrole compounds useful in treating iron disorders
AR068063A1 (es) * 2007-08-27 2009-11-04 Basf Plant Science Gmbh Co mpuestos de pirazol para controlar plagas de invertebrados
WO2009123316A1 (ja) * 2008-04-04 2009-10-08 武田薬品工業株式会社 複素環誘導体及びその用途
HRP20150842T1 (hr) 2008-04-28 2015-09-11 Kyorin Pharmaceutical Co., Ltd. Derivati ciklopentilakrilamida
US20140031547A1 (en) * 2010-12-14 2014-01-30 Electrophoretics Limited CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
CA2888889A1 (en) 2012-10-22 2014-05-01 Egenix, Inc. Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e
CN106458992B (zh) 2014-03-27 2019-03-15 默克专利股份公司 吡啶基哌啶
JP2018513870A (ja) 2015-04-24 2018-05-31 シンジェンタ パーティシペーションズ アーゲー 硫黄置換5員環複素環を有する殺有害生物的に活性な多環式誘導体
MX2017015456A (es) 2015-06-01 2018-11-29 Bantam Pharmaceutical Llc Compuestos de pirazol y pirrol sustituidos y metodos para su uso por inhibición de iniciación de traducción y tratamiento de enfermedades y trastornos relacionados con ellos.

Similar Documents

Publication Publication Date Title
JP2007510689A5 (enExample)
RU2426731C2 (ru) Производные арил-изоксазоло-4-ил-оксадиазола
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2016513660A5 (enExample)
RU2012148246A (ru) 5, 7- замещенные-имидазо[1, 2-с]пиримидины как ингибиторы jak-киназ
JP2010533158A5 (enExample)
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
RU2006112046A (ru) Производные пиррола с антибактериальным действием
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2016526576A5 (enExample)
JP2015517580A5 (enExample)
RU2010150786A (ru) Пирролопиридины как ингибиторы киназы
JP2017525757A5 (enExample)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2006500348A5 (enExample)
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
CA2729557A1 (en) Chemical compounds 251
JP2017508766A5 (enExample)
JP2010540462A5 (enExample)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
IL276575B1 (en) Inhibitors of btk and mutants thereof
JP2014528450A5 (enExample)
RU2015100942A (ru) Производное пиперидинилпиразолпиридина